Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization

Transplant International : Official Journal of the European Society for Organ Transplantation
G ColellaD Forti

Abstract

Between January 1989 and June 1997, 533 patients (423 male, 110 female, mean age 61 years, range 22-89 years) with hepatocellular carcinoma (HCC) were observed at our center. We report on 419 patients retrospectively compared for different treatments: liver transplantation (LT; 55 patients), resective surgery (RS; 41 patients), transarterial chemoembolization (TACE; 171 patients) and percutaneous ethanol injection (PEI; 152 patients). The 3- and 5-year actuarial survival rates were, respectively, 72% and 68% for LT, 64 and 44% for RS, 54 and 36% for PEI, and 32 and 22% for TACE. Survival curves were compared for sex, age, tumor characteristics, alphafetoprotein level, Child class, and etiology of cirrhosis. All patient-related characteristics examined (sex, age) are not significantly related to patient survival. Tumor-related variables and associated liver disease variables significantly conditioned survival in relation to different treatments. LT seems to be the treatment of choice for monofocal HCC less then 5 cm in diameter and in selected cases of plurifocal HCC.

Citations

Apr 16, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Peng GongZhongyu Wang
Dec 19, 2000·European Journal of Ultrasound : Official Journal of the European Federation of Societies for Ultrasound in Medicine and Biology·A GiorgioG Lettieri
Jun 6, 2003·Journal of the American College of Surgeons·Luciano De CarlisDomenico Forti
Dec 2, 2000·Journal of Gastroenterology and Hepatology·Z Y Tang
Feb 22, 2000·Radiographics : a Review Publication of the Radiological Society of North America, Inc·G D DoddH Rhim
Jan 24, 2003·AJR. American Journal of Roentgenology·Janio SzklarukChusilp Charnsangavej
Oct 18, 2013·World Journal of Surgery·Kenneth S H ChokChung Mau Lo
Jul 13, 2002·Expert Review of Anticancer Therapy·Y ShiratoriM Omata
Mar 3, 2015·World Journal of Hepatology·Tony Cy Pang, Vincent Wt Lam
Apr 11, 2007·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Seung Hyun ParkJin Wook Chung
Dec 5, 2006·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Yun Ku ChoJong-Hoon Byun
Jan 12, 2008·European Journal of Gastroenterology & Hepatology·Rune ErichsenHenrik T Sørensen
Oct 10, 2002·Clinical Transplantation·Robert A FisherMarc P Posner
Sep 13, 2003·World Journal of Gastroenterology : WJG·Jun QianThomas Vogl
Mar 6, 2015·Current Gastroenterology Reports·M Katherine Rude, Jeffrey S Crippin
Jun 22, 2011·Clinics in Liver Disease·Howard C Masuoka, Charles B Rosen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Related Papers

Current Opinion in Supportive and Palliative Care
Mohamed I F ShariffDavid Westaby
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology
Sunha BahngKwang Hyuck Lee
© 2022 Meta ULC. All rights reserved